{"id":218501,"date":"2025-12-24T00:00:00","date_gmt":"2025-12-24T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/47037381-medtech-peripheral-vascular-devices-market-insights\/"},"modified":"2026-04-24T05:02:31","modified_gmt":"2026-04-24T05:02:31","slug":"47042552-medtech-peripheral-vascular-devices-market-insights-united-states","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042552-medtech-peripheral-vascular-devices-market-insights-united-states\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; United States"},"content":{"rendered":"<p>The US <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective <abbr title=\"Peripheral Vascular\">PV<\/abbr> interventions and limited availability of certain products will hinder growth going forward.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the US <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market from 2019 through 2034.<\/p>\n<p><strong>The adoption of premium-priced devices will support US <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market growth.<\/strong><\/p>\n<p>How is the standard of care changing in the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device space due to adoption of innovative technologies?<\/p>\n<p>What limitations do new technologies face in terms of approved indications?<\/p>\n<p>To what extent will the limited availability of these technologies in nonhospital settings affect market growth?<\/p>\n<p><strong>The launch of innovative devices for treating <abbr data-display-abbreviation=\"Infrapop\" title=\"Infrapopliteal\">infrapop<\/abbr> (<abbr title=\"Below-the-Knee\">BTK<\/abbr>) lesions will bolster US <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market growth.<\/strong><\/p>\n<p>Which device types and technological innovations are being evaluated to address challenges in treating <abbr title=\"Below-the-Knee\">BTK<\/abbr> lesions?<\/p>\n<p>How has the entry of <abbr title=\"Bioresorbable Scaffold(s)\">BRS<\/abbr> affected adoption of endovascular techniques for <abbr data-display-abbreviation=\"Infrapop\" title=\"Infrapopliteal\">infrapop<\/abbr> indications?<\/p>\n<p>Which competitors stand to benefit from the launch of new devices, and how will this shape the market going forward?<\/p>\n<p><strong>Vessel preparation remains a critical step during interventional endovascular procedures for treating atherosclerosis.<\/strong><\/p>\n<p>How will adoption of <abbr title=\"Intravascular Lithotripsy\">IVL<\/abbr> reshape device choices during vessel revascularization procedures? Which devices are seeing increasing adoption?<\/p>\n<p>To what extent are atherectomy procedure volumes affected by current trends?<\/p>\n<p>Will specialty balloons represent a feasible alternative to <abbr title=\"Intravascular Lithotripsy\">IVL<\/abbr> or atherectomy?<\/p>\n<p><strong>Several key players in the <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market have expanded their US presence through acquisitions and partnerships.<\/strong><\/p>\n<p>Which key players are involved in acquisitions and partnerships, and how will these developments impact market share?<\/p>\n<p>How will companies that completed acquisitions adjust their marketing strategies to leverage expanded <abbr title=\"Peripheral Vascular\">PV<\/abbr> portfolios?<\/p>\n","protected":false},"template":"","class_list":["post-218501","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-united-states","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/218501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":7,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/218501\/revisions"}],"predecessor-version":[{"id":571862,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/218501\/revisions\/571862"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=218501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}